Form 4: Quest Diagnostics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Patrick Plewman, SVP at Quest Diagnostics, sold 320 shares of common stock on February 19, 2025, to cover tax withholding obligations.
Summary
- Patrick Plewman, a Senior Vice President at Quest Diagnostics, filed a Form 4 with the SEC.
- On February 19, 2025, Plewman sold 320 shares of Quest Diagnostics common stock at a price of $169.71 per share.
- The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units.
- Following the transaction, Plewman directly owns 18,082 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact sentiment.
Industry Context
Form 4 filings are routine disclosures of stock transactions by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small sale by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of stock sale transaction |
| 02/21/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.